GL1X · GenesisL1 explorer

Research workbench

Discovery of a potent cyclophilin inhibitor (compound 6) based on structural simplification of sanglifehrin a

Analyse Discovery of a potent cyclophilin inhibitor (compound 6) based on structural… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5T9Z
Type
protein
Length
163 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Peptidyl-prolyl cis-trans isomerase a
EC
5.2.1.8
UniProt
P62937
Ligands
78R

Structure

x-ray diffraction · 1 distinct chain · 14% helix, 33% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APeptidyl-prolyl cis-trans isomerase a (EC 5.2.1.8)protein16314% helix, 33% strandP62937

Ligands and binding sites

  • 78R · 11-[(3-hydroxyphenyl)methyl]-18-methoxy-17-methyl-14-(propan-2-yl)-3-oxa-9,12,15,28-tetraazatricyclo[21.3.1.1~5,9~]octacosa-1(27),21,23, 25-tetraene-4,10,13,16-tetrone · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 5T9Z · Discovery of a Potent Cyclophilin Inhibitor (Compound 6) based on Structural… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.